Your browser doesn't support javascript.
loading
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α.
Scuderi, Caterina; Valenza, Marta; Stecca, Claudia; Esposito, Giuseppe; Carratù, Maria Rosaria; Steardo, Luca.
Afiliación
  • Scuderi C; Department of Physiology and Pharmacology, SAPIENZA University of Rome, Rome, Italy.
J Neuroinflammation ; 9: 49, 2012 Mar 09.
Article en En | MEDLINE | ID: mdl-22405189
ABSTRACT

BACKGROUND:

In addition to cytotoxic mechanisms directly impacting neurons, ß-amyloid (Aß)-induced glial activation also promotes release of proinflammatory molecules that may self-perpetuate reactive gliosis and damage neighbouring neurons, thus amplifying neuropathological lesions occurring in Alzheimer's disease (AD). Palmitoylethanolamide (PEA) has been studied extensively for its anti-inflammatory, analgesic, antiepileptic and neuroprotective effects. PEA is a lipid messenger isolated from mammalian and vegetable tissues that mimics several endocannabinoid-driven actions, even though it does not bind to cannabinoid receptors. Some of its pharmacological properties are considered to be dependent on the expression of peroxisome proliferator-activated receptors-α (PPARα).

FINDINGS:

In the present study, we evaluated the effect of PEA on astrocyte activation and neuronal loss in models of Aß neurotoxicity. To this purpose, primary rat mixed neuroglial co-cultures and organotypic hippocampal slices were challenged with Aß1-42 and treated with PEA in the presence or absence of MK886 or GW9662, which are selective PPARα and PPARγ antagonists, respectively. The results indicate that PEA is able to blunt Aß-induced astrocyte activation and, subsequently, to improve neuronal survival through selective PPARα activation. The data from organotypic cultures confirm that PEA anti-inflammatory properties implicate PPARα mediation and reveal that the reduction of reactive gliosis subsequently induces a marked rebound neuroprotective effect on neurons.

CONCLUSIONS:

In line with our previous observations, the results of this study show that PEA treatment results in decreased numbers of infiltrating astrocytes during Aß challenge, resulting in significant neuroprotection. PEA could thus represent a promising pharmacological tool because it is able to reduce Aß-evoked neuroinflammation and attenuate its neurodegenerative consequences.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácidos Palmíticos / Neuroglía / Fármacos Neuroprotectores / PPAR alfa / Hipocampo Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Neuroinflammation Asunto de la revista: NEUROLOGIA Año: 2012 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ácidos Palmíticos / Neuroglía / Fármacos Neuroprotectores / PPAR alfa / Hipocampo Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: J Neuroinflammation Asunto de la revista: NEUROLOGIA Año: 2012 Tipo del documento: Article País de afiliación: Italia